Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Boehringer Ingelheim
Colorcon
Medtronic
Express Scripts

Last Updated: August 8, 2022

Investigational Drug Information for Phenylacetic acid


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the drug development status for Phenylacetic acid?

Phenylacetic acid is an investigational drug.

There have been 8 clinical trials for Phenylacetic acid. The most recent clinical trial was a Phase 1 trial, which was initiated on February 20th 2018.

The most common disease conditions in clinical trials are Drug-Related Side Effects and Adverse Reactions, Liver Cirrhosis, and Fibrosis. The leading clinical trial sponsors are Shijiazhuang Yiling Pharmaceutical Co. Ltd, Horizon Pharma Ireland, Ltd., Dublin Ireland, and Yiling Pharmaceutical Inc.

There are seven hundred and seventy-nine US patents protecting this investigational drug and forty-two international patents.

Recent Clinical Trials for Phenylacetic acid
TitleSponsorPhase
A Phase # Clinical Study Trial of Felbinac Trometamol Injection in ChinaShijiazhuang Yiling Pharmaceutical Co. LtdPhase 3
Glycerol-Phenylbutyrate Treatment in Children With MCT Mutation (Allan-Herndon- Dudley Syndrome)Weizmann Institute of SciencePhase 2/Phase 3
Glycerol-Phenylbutyrate Treatment in Children With MCT Mutation (Allan-Herndon- Dudley Syndrome)Kaplan Medical CenterPhase 2/Phase 3

See all Phenylacetic acid clinical trials

Clinical Trial Summary for Phenylacetic acid

Top disease conditions for Phenylacetic acid
Top clinical trial sponsors for Phenylacetic acid

See all Phenylacetic acid clinical trials

US Patents for Phenylacetic acid

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Phenylacetic acid See Plans and Pricing Compositions containing polymeric, ionic compounds comprising imidazolium groups BASF SE (Ludwigshafen, DE) See Plans and Pricing
Phenylacetic acid See Plans and Pricing Pyrrolidine amide compounds as histone demethylase inhibitors GENENTECH, INC. (South San Francisco, CA) CONSTELLATION PHARMACEUTICALS INC. (Cambridge, MA) See Plans and Pricing
Phenylacetic acid See Plans and Pricing Anti-viral compounds AbbVie Inc. (North Chicago, IL) See Plans and Pricing
Phenylacetic acid See Plans and Pricing Synthesis of levomethadone hydrochloride or dextromethadone hydrochloride and methods for use thereof Cody Laboratories, Inc. (Cody, WY) See Plans and Pricing
Phenylacetic acid See Plans and Pricing System and method for diagnosis and treatment See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Phenylacetic acid

Drugname Country Document Number Estimated Expiration Related US Patent
Phenylacetic acid China CN107001386 2034-10-11 See Plans and Pricing
Phenylacetic acid European Patent Office EP3204392 2034-10-11 See Plans and Pricing
Phenylacetic acid Japan JP2017531655 2034-10-11 See Plans and Pricing
Phenylacetic acid World Intellectual Property Organization (WIPO) WO2016055553 2034-10-11 See Plans and Pricing
Phenylacetic acid China CN105051106 2033-03-12 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Boehringer Ingelheim
Colorcon
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.